Support

Overview

Alzheimer’s disease is the most common type of dementia. This degenerative disease strikes the parts of the brain that controls memory, thought and language. Alzheimer’s is the sixth leading cause of death in the United States, and more than 5 million Americans are living with the disease. There is no cure.

The biggest risk factor for the disease is age. Most patients see symptoms start after age 60. While some cases may be inherited, most cases appear to be “spontaneous.” By studying the brains of people with Alzheimer’s, researchers have found that patients suffer from abnormal “plaques” of beta-amyloid proteins clustered around nerve cells. These brains also show tangled strands of proteins in dead and dying nerve cells. Over time, the connections break between nerve cells, and the brain shrinks.

Developing Alzheimer’s treatments will depend on a better understanding of what causes the disease in the first place.

Research Projects

Lindestam Arlehamn
Neurodegenerative Diseases

The aim of this work funded by Aligning Science Across Parkinson’s (ASAP), in collaboration with Dr. Alessandro Sette, is to

READ MORE
More research projects

Labs

Jan 6, 2022
Lindestam Arlehamn Lab

My laboratory is focused on understanding T cell immune responses to Mycobacterium tuberculosis and other infections, as well as self-antigens

Read More
LJI Research Assistant Professor Cecilia Lindestam Arlehamn, Ph.D.
Cecilia Lindestam Arlehamn, Ph.D.
Research Assistant Professor
Jul 2, 2020
Sette Lab

Alessandro Sette, Dr. Biol. Sci., defines in chemical terms the specific structures (epitopes) that the immune system recognizes and uses this knowledge to measure and understand immune responses.

Read More
Alessandro Sette, Dr.Biol.Sci.
Professor
Center for Autoimmunity and Inflammation, Center for Infectious Disease and Vaccine Research